Search

Your search keyword '"M. Piezzo"' showing total 48 results

Search Constraints

Start Over You searched for: Author "M. Piezzo" Remove constraint Author: "M. Piezzo"
48 results on '"M. Piezzo"'

Search Results

1. Constrained radar code design for spectrally congested environments via quadratic optimization

2. Constant modulus sequence set design with good correlation properties

3. Robust Design of Radar Doppler Filters

4. Radar waveform design in a spectrally crowded environment via nonconvex quadratic optimization

5. Sidelobe Blanking with Generalized Swerling-Chi Fluctuation Models

6. Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

7. Cognitive waveform design for spectral coexistence

8. Radar waveform design under similarity, bandwidth priority, and spectral coexistence constraints

9. Cognitive design of the receive filter and transmitted phase code in reverberating environment

10. Effects of Mutual Coupling of Radiating Antennas on an Adaptive Radar Detector

11. Design of Radar Receive Filters Optimized According to $L_{p}$-Norm Based Criteria

12. A Doppler Robust Max-Min Approach to Radar Code Design

13. Radar Filters Design in the Presence of Target Doppler Frequency and Interference Covariance Matrix Uncertainties

14. Pareto-theory for enabling covert intrapulse radar-embedded communications

15. Performance Prediction of the Incoherent Radar Detector for Correlated Generalized Swerling-Chi Fluctuating Targets

16. Quantized phase code and receive filter synthesis in reverberating environment

17. Performance prediction of the incoherent radar detector for Generalized Swerling-Chi fluctuating targets

18. Sidelobe blanking with correlated generalized Swerling-Chi fluctuation models

19. Intrapulse radar-embedded communications via multiobjective optimization

20. Cognitive design of the transmitted phase code and receive filter in reverberating environment

21. Cognitive radar waveform design for spectral coexistence in signal-dependent interference

22. Adaptive Detection of Point-Like Targets in the Presence of Homogeneous Clutter and Subspace Interference

23. Cognitive radar waveform design for spectral coexistence

24. Transmitted phase code/receive filter design for high reverberating environment: A cognitive approach

25. A coherent SLB architecture with Kelly's receiver

26. Non-Cooperative Code Design in Radar Networks: a Game-Theoretic Approach

27. Design of Pareto-Optimal Radar Receive Filters

28. Design of Optimized Radar Codes With a Peak to Average Power Ratio Constraint

29. Estimation of the covariance matrix based on multiple a-priori models

30. Pareto-optimal radar waveform design

31. Robust constrained waveform design for MIMO radar with uncertain steering vectors

32. Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis.

33. Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.

34. The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies.

35. Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center.

36. A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results.

37. Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies.

38. Clinical trials and drug cost savings for Italian health service.

39. Targeting Autophagy in Breast Cancer.

40. Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors.

41. Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

42. Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.

43. Gene Expression Assay in the Management of Early Breast Cancer.

44. Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.

45. Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.

46. Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.

47. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study.

48. Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.

Catalog

Books, media, physical & digital resources